Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.3 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 40.30.
Market Cap
8.3T
Revenue
4.52T
Profits
205.85B
PE Ratio
40.30
Profit Margin
4.55%
Dividend Yield
0.44%
1063 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 836.66B | -2.05% | 1,034,550 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 590.69B | 0.46% | 1,469,716 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 371.37B | -2.34% | 1,493,451 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 310.33B | 0.89% | 888,763 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 295.40B | -1.13% | 1,266,807 | 65.01B |
| 6 | NVS | Novartis AG | 295.40B | -0.55% | 1,804,749 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 250.69B | 0.81% | 1,601,480 | 447.57B |
| 8 | AMGN | Amgen Inc. | 188.13B | -1.21% | 429,096 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 185.66B | 1.06% | 412,035 | 44.56B |
| 10 | ABT | Abbott Laboratories | 179.39B | 0.61% | 1,456,991 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 173.54B | -0.35% | 1,349,235 | 29.44B |
| 12 | ISRG | Intuitive Surgical, Inc. | 163.81B | -0.70% | 364,361 | 10.06B |
| 13 | NVO | Novo Nordisk A/S | 163.38B | -0.16% | 5,182,754 | 48.59B |
| 14 | PFE | Pfizer Inc. | 161.89B | -0.32% | 9,840,544 | 62.58B |
| 15 | DHR | Danaher Corporation | 135.24B | 0.16% | 651,544 | 24.57B |
| 16 | SYK | Stryker Corporation | 126.64B | 0.46% | 403,317 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 121.46B | -3.63% | 4,072,161 | 48.19B |
| 18 | SNY | Sanofi | 116.20B | -0.23% | 519,602 | 54.85B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 112.19B | -1.25% | 351,589 | 12.00B |
| 20 | GSK | GSK plc | 112.19B | 1.20% | 1,630,072 | 43.97B |
| 21 | MDT | Medtronic plc | 110.88B | 0.35% | 1,195,437 | 35.48B |
| 22 | MCK | McKesson Corporation | 107.90B | 0.98% | 203,899 | 397.96B |
| 23 | HCA | HCA Healthcare, Inc. | 105.40B | -0.70% | 138,962 | 75.60B |
| 24 | BSX | Boston Scientific Corporation | 93.72B | 1.71% | 3,562,600 | 20.07B |
| 25 | CVS | CVS Health Corporation | 93.48B | 1.37% | 1,475,904 | 399.83B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 76.89B | -3.60% | 318,154 | 14.34B |
| 27 | CI | The Cigna Group | 71.13B | 0.92% | 171,818 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 66.24B | 1.02% | 330,888 | 199.13B |
| 29 | COR | Cencora, Inc. | 62.20B | 0.66% | 324,492 | 325.78B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 58.66B | - | 998,665 | 28.48B |
| 31 | MDLN | Medline Inc. | 57.67B | -0.23% | 1,591,334 | 28.43B |
| 32 | CAH | Cardinal Health, Inc. | 50.36B | 0.95% | 321,533 | 244.67B |
| 33 | ZTS | Zoetis Inc. | 49.73B | 0.44% | 604,326 | 9.47B |
| 34 | EW | Edwards Lifesciences Corporation | 46.87B | 0.04% | 631,508 | 6.07B |
| 35 | ARGX | argenx SE | 46.54B | 0.46% | 213,156 | 4.24B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.95B | -0.02% | 211,858 | 4.30B |
| 37 | BDX | Becton, Dickinson and Company | 44.47B | -0.10% | 533,621 | 21.92B |
| 38 | HLN | Haleon plc | 44.14B | - | 1,770,000 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.50B | -2.52% | 283,269 | 3.71B |
| 40 | ALC | Alcon Inc. | 36.89B | 0.12% | 345,773 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 34.87B | -1.02% | 829,270 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 34.60B | 1.15% | 43,649 | 5.34B |
| 43 | INSM | Insmed Incorporated | 34.27B | -3.55% | 535,680 | 606.42M |
| 44 | GEHC | GE HealthCare Technologies Inc. | 32.53B | -0.96% | 646,113 | 20.63B |
| 45 | A | Agilent Technologies, Inc. | 32.46B | 0.28% | 271,646 | 7.07B |
| 46 | RMD | ResMed Inc. | 32.44B | 0.36% | 152,126 | 5.40B |
| 47 | NTRA | Natera, Inc. | 29.73B | 3.22% | 447,404 | 2.31B |
| 48 | WAT | Waters Corporation | 29.48B | 0.21% | 212,737 | 3.17B |
| 49 | IQV | IQVIA Holdings Inc. | 29.20B | 0.91% | 216,932 | 16.31B |
| 50 | VEEV | Veeva Systems Inc. | 28.40B | 0.67% | 394,796 | 3.20B |
| 51 | RPRX | Royalty Pharma plc | 28.23B | 0.93% | 992,659 | 2.38B |
| 52 | BIIB | Biogen Inc. | 26.21B | -2.84% | 365,280 | 9.89B |
| 53 | PHG | Koninklijke Philips N.V. | 26.07B | -0.24% | 488,258 | 20.94B |
| 54 | MTD | Mettler-Toledo International Inc. | 25.82B | 0.08% | 24,168 | 4.03B |
| 55 | UTHR | United Therapeutics Corporation | 24.34B | -2.60% | 226,818 | 3.18B |
| 56 | DXCM | DexCom, Inc. | 23.88B | -0.53% | 784,135 | 4.66B |
| 57 | LH | Labcorp Holdings Inc. | 22.59B | 0.54% | 125,460 | 13.95B |
| 58 | DGX | Quest Diagnostics Incorporated | 21.70B | -0.09% | 104,045 | 11.04B |
| 59 | BNTX | BioNTech SE | 21.56B | 0.47% | 199,114 | 3.37B |
| 60 | STE | STERIS plc | 21.48B | -0.43% | 183,034 | 5.83B |
| 61 | HUM | Humana Inc. | 21.44B | 0.93% | 263,586 | 129.66B |
| 62 | ROIV | Roivant Sciences Ltd. | 20.07B | 0.72% | 1,441,927 | 13.31M |
| 63 | RVMD | Revolution Medicines, Inc. | 19.83B | 1.42% | 297,668 | - |
| 64 | ILMN | Illumina, Inc. | 19.56B | 1.01% | 210,748 | 4.34B |
| 65 | MRNA | Moderna, Inc. | 19.42B | -2.10% | 1,335,925 | 1.94B |
| 66 | INCY | Incyte Corporation | 18.88B | 0.59% | 203,307 | 5.14B |
| 67 | WST | West Pharmaceutical Services, Inc. | 18.31B | 0.58% | 133,710 | 3.07B |
| 68 | ZBH | Zimmer Biomet Holdings, Inc. | 17.81B | 0.02% | 722,793 | 8.23B |
| 69 | CNC | Centene Corporation | 17.18B | 2.89% | 1,283,989 | 176.15B |
| 70 | HOLX | Hologic, Inc. | 16.88B | - | 1,705,993 | 4.13B |
| 71 | GMAB | Genmab A/S | 16.77B | -0.29% | 174,949 | 3.72B |
| 72 | THC | Tenet Healthcare Corporation | 16.32B | -1.34% | 140,840 | 21.31B |
| 73 | VTRS | Viatris Inc. | 15.50B | -1.25% | 1,373,540 | 14.30B |
| 74 | SMMT | Summit Therapeutics Inc. | 15.23B | 3.81% | 1,258,839 | - |
| 75 | RGC | Regencell Bioscience Holdings Limited | 15.18B | -8.96% | 213,230 | - |
| 76 | PODD | Insulet Corporation | 14.53B | -0.30% | 149,821 | 2.71B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 14.16B | -1.87% | 334,498 | 502.08M |
| 78 | MEDP | Medpace Holdings, Inc. | 14.11B | 1.56% | 95,564 | 2.53B |
| 79 | COO | The Cooper Companies, Inc. | 13.89B | -0.34% | 354,176 | 4.15B |
| 80 | ASND | Ascendis Pharma A/S | 13.76B | -1.75% | 269,550 | 845.52M |
| 81 | SNN | Smith & Nephew plc | 13.58B | -0.34% | 387,338 | 6.16B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 13.12B | -1.35% | 180,979 | 2.86B |
| 83 | PEN | Penumbra, Inc. | 12.97B | 0.47% | 238,502 | 1.40B |
| 84 | ALGN | Align Technology, Inc. | 12.31B | -0.06% | 414,819 | 4.03B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.25B | -1.30% | 257,258 | 943.71M |
| 86 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.18B | 0.23% | 84,049 | 958.40M |
| 87 | FMS | Fresenius Medical Care AG | 12.16B | -0.22% | 94,522 | 23.05B |
| 88 | GH | Guardant Health, Inc. | 12.04B | 0.71% | 651,437 | 982.02M |
| 89 | GMED | Globus Medical, Inc. | 11.98B | 0.92% | 256,897 | 2.94B |
| 90 | JAZZ | Jazz Pharmaceuticals plc | 11.53B | -0.51% | 165,929 | 4.27B |
| 91 | ELAN | Elanco Animal Health Incorporated | 11.36B | -1.21% | 1,133,426 | 4.72B |
| 92 | ENSG | The Ensign Group, Inc. | 11.35B | -1.69% | 107,387 | 5.06B |
| 93 | EXEL | Exelixis, Inc. | 11.31B | -1.09% | 391,531 | 2.32B |
| 94 | SOLV | Solventum Corporation | 11.06B | -0.89% | 220,713 | 8.33B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 10.88B | -1.45% | 2,033,740 | 3.85B |
| 96 | UHS | Universal Health Services, Inc. | 10.73B | -1.28% | 144,780 | 17.36B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.69B | -2.87% | 666,565 | 3.22B |
| 98 | RVTY | Revvity, Inc. | 9.91B | 0.84% | 134,585 | 2.86B |
| 99 | DVA | DaVita Inc. | 9.83B | -2.12% | 279,141 | 13.64B |
| 100 | EHC | Encompass Health Corporation | 9.65B | -0.33% | 127,805 | 5.94B |
| 101 | ABVX | ABIVAX Société Anonyme | 9.38B | 1.97% | 466,359 | 5.37M |
| 102 | MASI | Masimo Corporation | 9.30B | 0.11% | 460,565 | 1.53B |
| 103 | PRAX | Praxis Precision Medicines, Inc. | 8.74B | -1.74% | 130,488 | 7.46M |
| 104 | BTSG | BrightSpring Health Services, Inc. | 8.72B | 1.59% | 438,353 | 12.91B |
| 105 | BAX | Baxter International Inc. | 8.69B | 0.36% | 1,775,786 | 11.24B |
| 106 | ICLR | ICON Public Limited Company | 8.68B | 2.04% | 201,881 | 8.10B |
| 107 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.66B | -1.72% | 396,491 | 1.09B |
| 108 | AXSM | Axsome Therapeutics, Inc. | 8.58B | -2.35% | 160,713 | 638.50M |
| 109 | TEM | Tempus AI, Inc. | 8.46B | 0.68% | 1,857,180 | 1.27B |
| 110 | CRL | Charles River Laboratories International, Inc. | 8.45B | -1.89% | 237,831 | 4.02B |
| 111 | HSIC | Henry Schein, Inc. | 8.44B | 0.78% | 274,452 | 13.18B |
| 112 | QGEN | Qiagen N.V. | 8.36B | 0.45% | 486,969 | 2.09B |
| 113 | TECH | Bio-Techne Corporation | 8.35B | -0.17% | 542,026 | 1.22B |
| 114 | PCVX | Vaxcyte, Inc. | 8.33B | -1.11% | 199,360 | - |
| 115 | CYTK | Cytokinetics, Incorporated | 8.22B | 0.20% | 898,105 | 88.04M |
| 116 | NUVL | Nuvalent, Inc. | 8.14B | -1.96% | 205,501 | - |
| 117 | ATR | AptarGroup, Inc. | 7.99B | -1.13% | 46,535 | 3.78B |
| 118 | HALO | Halozyme Therapeutics, Inc. | 7.64B | -1.39% | 200,828 | 1.40B |
| 119 | BIO | Bio-Rad Laboratories, Inc. | 7.54B | 0.36% | 67,723 | 2.58B |
| 120 | KRYS | Krystal Biotech, Inc. | 7.51B | -0.81% | 123,704 | 389.13M |
| 121 | IBRX | ImmunityBio, Inc. | 7.45B | 0.98% | 6,786,179 | 113.29M |
| 122 | MOH | Molina Healthcare, Inc. | 7.22B | 2.07% | 232,308 | 43.56B |
| 123 | HQY | HealthEquity, Inc. | 7.11B | 0.89% | 141,430 | 1.31B |
| 124 | KYMR | Kymera Therapeutics, Inc. | 6.92B | -0.24% | 161,400 | 39.21M |
| 125 | BLTE | Belite Bio, Inc | 6.87B | 4.35% | 57,794 | - |
| 126 | ACLX | Arcellx, Inc. | 6.73B | -0.01% | 509,679 | 22.29M |
| 127 | RGEN | Repligen Corporation | 6.70B | 0.57% | 133,338 | 738.26M |
| 128 | GRFS | Grifols, S.A. | 6.67B | -1.21% | 439,794 | 8.83B |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 6.59B | -0.40% | 67,004 | 46.02M |
| 130 | GKOS | Glaukos Corporation | 6.57B | 0.44% | 143,709 | 507.44M |
| 131 | APGE | Apogee Therapeutics, Inc. | 6.18B | -0.59% | 120,588 | - |
| 132 | CNTA | Centessa Pharmaceuticals plc | 6.14B | -0.44% | 1,700,344 | 15.00M |
| 133 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | -0.14% | 4,638,428 | - |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.94B | -1.34% | 151,810 | 189.76M |
| 135 | BLCO | Bausch + Lomb Corporation | 5.92B | 0.12% | 101,290 | 5.10B |
| 136 | ALKS | Alkermes plc | 5.79B | -0.57% | 760,685 | 1.48B |
| 137 | MIRM | Mirum Pharmaceuticals, Inc. | 5.68B | -0.59% | 127,699 | 521.31M |
| 138 | CGON | CG Oncology, Inc. | 5.65B | 0.12% | 237,077 | 4.04M |
| 139 | SRRK | Scholar Rock Holding Corporation | 5.64B | -0.53% | 667,041 | - |
| 140 | COGT | Cogent Biosciences, Inc. | 5.61B | -1.16% | 609,223 | - |
| 141 | PTCT | PTC Therapeutics, Inc. | 5.59B | -1.69% | 117,354 | 1.73B |
| 142 | BRKR | Bruker Corporation | 5.58B | 1.52% | 372,608 | 3.44B |
| 143 | ERAS | Erasca, Inc. | 5.48B | 6.27% | 2,345,792 | - |
| 144 | CELC | Celcuity Inc. | 5.45B | -0.09% | 151,180 | - |
| 145 | CAI | Caris Life Sciences, Inc. | 5.42B | 0.34% | 282,119 | 812.03M |
| 146 | XENE | Xenon Pharmaceuticals Inc. | 5.39B | -0.28% | 302,568 | 7.50M |
| 147 | AVTR | Avantor, Inc. | 5.29B | 0.71% | 1,451,833 | 6.55B |
| 148 | TFX | Teleflex Incorporated | 5.21B | -0.50% | 132,107 | 1.99B |
| 149 | CHE | Chemed Corporation | 5.18B | -0.41% | 41,641 | 2.53B |
| 150 | APLS | Apellis Pharmaceuticals, Inc. | 5.17B | 0.12% | 4,488,399 | 1.00B |
| 151 | TGTX | TG Therapeutics, Inc. | 5.03B | 1.49% | 438,235 | 616.29M |
| 152 | IMVT | Immunovant, Inc. | 5.03B | -1.49% | 910,750 | - |
| 153 | PACS | PACS Group, Inc. | 5.01B | 0.63% | 103,560 | 5.29B |
| 154 | LNTH | Lantheus Holdings, Inc. | 4.94B | 0.52% | 74,893 | 1.54B |
| 155 | CRSP | CRISPR Therapeutics AG | 4.64B | -1.00% | 548,044 | 3.51M |
| 156 | WAY | Waystar Holding Corp. | 4.64B | 1.77% | 510,373 | 1.10B |
| 157 | CORT | Corcept Therapeutics Incorporated | 4.60B | 3.07% | 380,054 | 761.41M |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 4.57B | 2.16% | 155,405 | 2.04M |
| 159 | FOLD | Amicus Therapeutics, Inc. | 4.53B | -0.03% | 1,654,629 | 634.21M |
| 160 | HIMS | Hims & Hers Health, Inc. | 4.37B | -3.43% | 10,806,256 | 2.35B |
| 161 | RDNT | RadNet, Inc. | 4.27B | -0.60% | 277,388 | 2.04B |
| 162 | OPCH | Option Care Health, Inc. | 4.23B | 2.15% | 476,452 | 5.65B |
| 163 | SHC | Sotera Health Company | 4.22B | -0.13% | 1,503,122 | 1.16B |
| 164 | NVST | Envista Holdings Corporation | 4.21B | -0.73% | 368,033 | 2.72B |
| 165 | DOCS | Doximity, Inc. | 4.19B | -1.13% | 748,503 | 637.78M |
| 166 | MMSI | Merit Medical Systems, Inc. | 4.05B | -0.21% | 142,681 | 1.52B |
| 167 | MMED | Minimed Group, Inc. | 4.03B | -0.90% | 201,984 | 2.89B |
| 168 | AMRX | Amneal Pharmaceuticals, Inc. | 4.01B | -1.10% | 233,241 | 3.02B |
| 169 | LGND | Ligand Pharmaceuticals Incorporated | 3.99B | 0.14% | 79,012 | 268.09M |
| 170 | VKTX | Viking Therapeutics, Inc. | 3.95B | 3.64% | 1,071,036 | - |
| 171 | BLLN | BillionToOne, Inc. | 3.89B | 1.89% | 134,073 | 305.11M |
| 172 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.84B | 0.33% | 216,055 | 7.70M |
| 173 | GPCR | Structure Therapeutics Inc. | 3.83B | 7.78% | 616,685 | - |
| 174 | STVN | Stevanato Group S.p.A. | 3.81B | 1.49% | 80,299 | 1.39B |
| 175 | ACAD | ACADIA Pharmaceuticals Inc. | 3.79B | -0.31% | 839,371 | 1.07B |
| 176 | ALHC | Alignment Healthcare, Inc. | 3.79B | 3.92% | 1,034,357 | 3.95B |
| 177 | IRTC | iRhythm Holdings, Inc. | 3.79B | -0.84% | 157,981 | 747.14M |
| 178 | NAMS | NewAmsterdam Pharma Company N.V. | 3.79B | 0.35% | 228,559 | 22.50M |
| 179 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.68B | -0.02% | 96,405 | 677.56M |
| 180 | SYRE | Spyre Therapeutics, Inc. | 3.68B | -4.25% | 119,944 | - |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 3.55B | -0.15% | 213,873 | - |
| 182 | LIVN | LivaNova PLC | 3.53B | -0.05% | 114,243 | 1.39B |
| 183 | LEGN | Legend Biotech Corporation | 3.53B | 0.10% | 414,412 | 1.03B |
| 184 | OSCR | Oscar Health, Inc. | 3.50B | 0.34% | 1,214,105 | 11.70B |
| 185 | TMDX | TransMedics Group, Inc. | 3.45B | 0.07% | 189,356 | 605.49M |
| 186 | BKD | Brookdale Senior Living Inc. | 3.29B | -0.11% | 520,299 | 3.05B |
| 187 | LQDA | Liquidia Corporation | 3.25B | -1.48% | 146,996 | 158.32M |
| 188 | DNLI | Denali Therapeutics Inc. | 3.22B | 3.23% | 427,580 | - |
| 189 | ICUI | ICU Medical, Inc. | 3.14B | 0.34% | 117,698 | 2.23B |
| 190 | TNGX | Tango Therapeutics, Inc. | 3.12B | 3.20% | 1,322,106 | 62.38M |
| 191 | HNGE | Hinge Health, Inc. | 3.08B | 1.53% | 172,418 | 587.86M |
| 192 | TWST | Twist Bioscience Corporation | 3.05B | 0.50% | 308,168 | 391.56M |
| 193 | DYN | Dyne Therapeutics, Inc. | 3.05B | 1.99% | 756,566 | - |
| 194 | TLX | Telix Pharmaceuticals Limited | 3.04B | -1.24% | 84,444 | 803.79M |
| 195 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.01B | -0.81% | 116,512 | 588.99M |
| 196 | TARS | Tarsus Pharmaceuticals, Inc. | 3.00B | 0.54% | 50,679 | 451.36M |
| 197 | ALMS | Alumis Inc. | 3.00B | 3.83% | 327,450 | 24.05M |
| 198 | ITGR | Integer Holdings Corporation | 2.98B | 0.17% | 52,937 | 1.85B |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 2.94B | -1.78% | 161,761 | 376.07M |
| 200 | RCUS | Arcus Biosciences, Inc. | 2.92B | 6.55% | 678,827 | 247.00M |
| 201 | SUPN | Supernus Pharmaceuticals, Inc. | 2.91B | -1.85% | 87,847 | 718.95M |
| 202 | TXG | 10x Genomics, Inc. | 2.88B | 2.13% | 407,174 | 642.82M |
| 203 | IDYA | IDEAYA Biosciences, Inc. | 2.87B | 0.63% | 205,247 | 218.71M |
| 204 | VERA | Vera Therapeutics, Inc. | 2.87B | -0.77% | 191,271 | - |
| 205 | TVTX | Travere Therapeutics, Inc. | 2.84B | -2.13% | 382,060 | 490.73M |
| 206 | CON | Concentra Group Holdings Parent, Inc. | 2.70B | -1.13% | 112,755 | 2.16B |
| 207 | HAE | Haemonetics Corporation | 2.64B | 1.08% | 68,987 | 1.32B |
| 208 | ORKA | Oruka Therapeutics, Inc. | 2.62B | 4.82% | 554,031 | - |
| 209 | PBH | Prestige Consumer Healthcare Inc. | 2.61B | -4.44% | 473,321 | 1.10B |
| 210 | PRVA | Privia Health Group, Inc. | 2.58B | -0.90% | 184,246 | 2.12B |
| 211 | VCYT | Veracyte, Inc. | 2.57B | -0.17% | 184,216 | 517.15M |
| 212 | HCM | HUTCHMED (China) Limited | 2.54B | -0.40% | 8,323 | 548.51M |
| 213 | IMNM | Immunome, Inc. | 2.51B | -1.07% | 333,586 | 6.94M |
| 214 | WRBY | Warby Parker Inc. | 2.49B | -4.86% | 728,742 | 871.91M |
| 215 | IRON | Disc Medicine, Inc. | 2.49B | 0.76% | 97,840 | - |
| 216 | NHC | National HealthCare Corporation | 2.49B | 1.29% | 47,704 | 1.52B |
| 217 | LMAT | LeMaitre Vascular, Inc. | 2.49B | 0.34% | 57,535 | 249.60M |
| 218 | LFST | LifeStance Health Group, Inc. | 2.46B | -1.02% | 296,931 | 1.42B |
| 219 | AAPG | Ascentage Pharma Group International | 2.44B | 2.08% | 2,825 | 82.08M |
| 220 | KOD | Kodiak Sciences Inc. | 2.43B | -7.94% | 586,108 | - |
| 221 | BEAM | Beam Therapeutics Inc. | 2.43B | 0.95% | 696,051 | 139.74M |
| 222 | SRPT | Sarepta Therapeutics, Inc. | 2.42B | 4.20% | 959,849 | 2.20B |
| 223 | GRDN | Guardian Pharmacy Services, Inc. | 2.40B | 0.88% | 150,253 | 1.45B |
| 224 | ZLAB | Zai Lab Limited | 2.32B | 1.23% | 294,050 | 460.16M |
| 225 | XRAY | DENTSPLY SIRONA Inc. | 2.32B | -0.30% | 936,739 | 3.68B |
| 226 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.29B | -2.45% | 4,349,402 | 874.84M |
| 227 | ADPT | Adaptive Biotechnologies Corporation | 2.27B | 2.08% | 333,260 | 276.98M |
| 228 | ELVN | Enliven Therapeutics, Inc. | 2.25B | -0.32% | 193,216 | - |
| 229 | PAHC | Phibro Animal Health Corporation | 2.25B | 1.22% | 68,217 | 1.46B |
| 230 | GRAL | GRAIL, Inc. | 2.24B | 1.68% | 246,616 | 147.17M |
| 231 | MANE | Veradermics, Incorporated | 2.23B | 1.80% | 192,226 | - |
| 232 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | 0.07% | 412,887 | 158.18M |
| 233 | RLAY | Relay Therapeutics, Inc. | 2.21B | 14.86% | 3,632,150 | 15.36M |
| 234 | ACHC | Acadia Healthcare Company, Inc. | 2.19B | 0.38% | 449,457 | 3.31B |
| 235 | NKTR | Nektar Therapeutics | 2.18B | 0.17% | 198,410 | 55.23M |
| 236 | ADMA | ADMA Biologics, Inc. | 2.17B | -0.05% | 1,684,917 | 510.17M |
| 237 | SNDX | Syndax Pharmaceuticals, Inc. | 2.17B | 2.89% | 923,089 | 172.35M |
| 238 | RARE | Ultragenyx Pharmaceutical Inc. | 2.15B | 2.43% | 490,983 | 673.00M |
| 239 | TYRA | Tyra Biosciences, Inc. | 2.15B | 4.05% | 367,586 | - |
| 240 | MLYS | Mineralys Therapeutics, Inc. | 2.14B | -1.63% | 136,949 | - |
| 241 | HTFL | HeartFlow, Inc. | 2.10B | -0.16% | 316,929 | 176.03M |
| 242 | DFTX | Definium Therapeutics, Inc. | 2.08B | 1.36% | 773,842 | - |
| 243 | CLDX | Celldex Therapeutics, Inc. | 2.05B | -1.34% | 2,305,529 | 1.55M |
| 244 | AGIO | Agios Pharmaceuticals, Inc. | 2.05B | 2.40% | 383,530 | 54.03M |
| 245 | BHC | Bausch Health Companies Inc. | 2.04B | -1.25% | 254,359 | 10.27B |
| 246 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | -0.97% | 219,383 | 283.06M |
| 247 | SEM | Select Medical Holdings Corporation | 2.02B | 0.09% | 274,318 | 5.45B |
| 248 | NEOG | Neogen Corporation | 2.01B | -1.60% | 775,208 | 880.32M |
| 249 | AHG | Akso Health Group | 2.00B | 0.43% | 150,548 | 14.84M |
| 250 | GLPG | Galapagos NV | 1.98B | -0.86% | 110,144 | 1.31B |
| 251 | SLNO | Soleno Therapeutics, Inc. | 1.98B | 3.91% | 1,506,293 | 190.41M |
| 252 | ZYME | Zymeworks Inc. | 1.94B | 1.56% | 195,409 | 105.97M |
| 253 | VRDN | Viridian Therapeutics, Inc. | 1.94B | -0.78% | 938,367 | 70.85M |
| 254 | WGS | GeneDx Holdings Corp. | 1.91B | -0.35% | 99,756 | 427.54M |
| 255 | MESO | Mesoblast Limited | 1.91B | -5.47% | 52,716 | 65.38M |
| 256 | STOK | Stoke Therapeutics, Inc. | 1.88B | -0.56% | 162,657 | 184.42M |
| 257 | SION | Sionna Therapeutics, Inc. | 1.87B | 0.65% | 160,500 | - |
| 258 | OCUL | Ocular Therapeutix, Inc. | 1.86B | 2.52% | 1,610,830 | 51.95M |
| 259 | PHVS | Pharvaris N.V. | 1.83B | -4.24% | 67,573 | - |
| 260 | CAPR | Capricor Therapeutics, Inc. | 1.83B | 5.58% | 519,102 | 11.13M |
| 261 | AXGN | Axogen, Inc. | 1.78B | 2.38% | 113,879 | 225.21M |
| 262 | GENB | Generate Biomedicines, Inc. | 1.74B | 2.40% | 98,466 | 31.89M |
| 263 | ESTA | Establishment Labs Holdings Inc. | 1.72B | 0.02% | 93,511 | 211.08M |
| 264 | ANAB | AnaptysBio, Inc. | 1.72B | 5.41% | 112,890 | 234.60M |
| 265 | INVA | Innoviva, Inc. | 1.71B | -1.11% | 123,234 | 411.33M |
| 266 | MD | Pediatrix Medical Group, Inc. | 1.70B | 1.01% | 225,452 | 1.91B |
| 267 | ATEC | Alphatec Holdings, Inc. | 1.69B | -1.07% | 565,835 | 764.16M |
| 268 | ADUS | Addus HomeCare Corporation | 1.68B | -1.05% | 34,837 | 1.42B |
| 269 | PVLA | Palvella Therapeutics, Inc. | 1.66B | -3.56% | 143,143 | - |
| 270 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.65B | 4.11% | 255,098 | -665.00K |
| 271 | OGN | Organon & Co. | 1.65B | 2.93% | 1,178,701 | 6.22B |
| 272 | VCEL | Vericel Corporation | 1.64B | -1.12% | 89,921 | 276.26M |
| 273 | AORT | Artivion, Inc. | 1.63B | -0.15% | 120,717 | 441.33M |
| 274 | RXRX | Recursion Pharmaceuticals, Inc. | 1.63B | 0.98% | 3,104,516 | 74.68M |
| 275 | NBTX | Nanobiotix S.A. | 1.63B | -6.28% | 79,384 | 38.27M |
| 276 | AHCO | AdaptHealth Corp. | 1.62B | 0.51% | 364,228 | 3.24B |
| 277 | NRIX | Nurix Therapeutics, Inc. | 1.60B | -0.26% | 286,441 | 83.98M |
| 278 | HRMY | Harmony Biosciences Holdings, Inc. | 1.59B | -1.72% | 156,302 | 868.45M |
| 279 | RAPP | Rapport Therapeutics, Inc. | 1.58B | 4.33% | 60,610 | - |
| 280 | OCS | Oculis Holding AG | 1.58B | -1.48% | 27,316 | 1.51M |
| 281 | ANIP | ANI Pharmaceuticals, Inc. | 1.57B | -0.98% | 86,099 | 883.37M |
| 282 | PLSE | Pulse Biosciences, Inc. | 1.56B | -0.11% | 62,972 | 350.00K |
| 283 | SGRY | Surgery Partners, Inc. | 1.56B | -0.77% | 369,354 | 3.31B |
| 284 | MBX | MBX Biosciences, Inc. | 1.56B | 1.66% | 192,512 | - |
| 285 | IMCR | Immunocore Holdings plc | 1.55B | 1.06% | 74,278 | 400.02M |
| 286 | NTLA | Intellia Therapeutics, Inc. | 1.55B | -1.28% | 1,203,807 | 67.67M |
| 287 | OMCL | Omnicell, Inc. | 1.54B | -0.12% | 55,779 | 1.18B |
| 288 | DMRA | Damora Therapeutics, Inc. | 1.54B | 1.71% | 66,083 | - |
| 289 | INSP | Inspire Medical Systems, Inc. | 1.53B | -0.73% | 216,714 | 911.98M |
| 290 | NUVB | Nuvation Bio Inc. | 1.53B | -0.89% | 703,947 | 62.90M |
| 291 | TRVI | Trevi Therapeutics, Inc. | 1.53B | 2.59% | 348,662 | - |
| 292 | PRGO | Perrigo Company plc | 1.51B | - | 997,064 | 4.25B |
| 293 | UFPT | UFP Technologies, Inc. | 1.49B | -0.58% | 89,739 | 602.80M |
| 294 | SNDA | Sonida Senior Living, Inc. | 1.48B | -1.28% | 140,080 | 336.39M |
| 295 | BHVN | Biohaven Ltd. | 1.48B | 2.08% | 985,465 | - |
| 296 | VIR | Vir Biotechnology, Inc. | 1.46B | 1.55% | 733,117 | 68.56M |
| 297 | ARDX | Ardelyx, Inc. | 1.46B | -2.62% | 796,007 | 407.32M |
| 298 | PRCT | PROCEPT BioRobotics Corporation | 1.43B | 0.20% | 201,243 | 308.05M |
| 299 | SVRA | Savara Inc. | 1.43B | 1.08% | 212,647 | - |
| 300 | MAZE | Maze Therapeutics, Inc. | 1.42B | -1.38% | 295,432 | 2.50M |
| 301 | ATRC | AtriCure, Inc. | 1.42B | 0.88% | 181,979 | 534.53M |
| 302 | IOVA | Iovance Biotherapeutics, Inc. | 1.41B | -0.58% | 2,186,508 | 263.50M |
| 303 | AVAH | Aveanna Healthcare Holdings Inc. | 1.39B | 1.91% | 224,684 | 2.43B |
| 304 | BCAX | Bicara Therapeutics Inc. | 1.39B | 3.83% | 290,758 | - |
| 305 | IMTX | Immatics N.V. | 1.39B | 3.75% | 231,807 | 56.67M |
| 306 | PGEN | Precigen, Inc. | 1.39B | - | 1,338,585 | 9.68M |
| 307 | GLUE | Monte Rosa Therapeutics, Inc. | 1.38B | 0.76% | 362,424 | 123.67M |
| 308 | HROW | Harrow, Inc. | 1.35B | 2.06% | 133,125 | 272.30M |
| 309 | ATAI | AtaiBeckley Inc. | 1.34B | -0.68% | 949,807 | 4.09M |
| 310 | ENOV | Enovis Corporation | 1.32B | -1.50% | 151,900 | 2.25B |
| 311 | WVE | Wave Life Sciences Ltd. | 1.30B | 1.46% | 1,020,219 | 42.73M |
| 312 | PGNY | Progyny, Inc. | 1.29B | -1.96% | 419,597 | 1.29B |
| 313 | TNDM | Tandem Diabetes Care, Inc. | 1.29B | 0.32% | 255,219 | 1.01B |
| 314 | OLMA | Olema Pharmaceuticals, Inc. | 1.29B | -2.25% | 242,432 | - |
| 315 | HCSG | Healthcare Services Group, Inc. | 1.27B | 1.18% | 217,353 | 1.84B |
| 316 | NVAX | Novavax, Inc. | 1.27B | -3.12% | 1,198,909 | 1.12B |
| 317 | TSHA | Taysha Gene Therapies, Inc. | 1.25B | 1.04% | 458,024 | 9.77M |
| 318 | IRMD | IRADIMED CORPORATION | 1.23B | -0.20% | 23,651 | 83.81M |
| 319 | ZBIO | Zenas BioPharma, Inc. | 1.23B | 1.57% | 334,167 | 10.00M |
| 320 | ASTH | Astrana Health, Inc. | 1.23B | 1.39% | 123,169 | 3.18B |
| 321 | ARDT | Ardent Health, Inc. | 1.22B | -1.27% | 45,398 | 6.32B |
| 322 | MLTX | MoonLake Immunotherapeutics | 1.21B | 2.30% | 383,938 | - |
| 323 | DBVT | DBV Technologies S.A. | 1.21B | 1.85% | 240,431 | 5.64M |
| 324 | CRVS | Corvus Pharmaceuticals, Inc. | 1.21B | -0.07% | 212,705 | - |
| 325 | NVCR | NovoCure Limited | 1.21B | -1.94% | 154,698 | 655.35M |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.18B | 1.12% | 55,728 | 83.72M |
| 327 | PHAR | Pharming Group N.V. | 1.16B | -0.71% | 6,945 | 376.13M |
| 328 | QDEL | QuidelOrtho Corporation | 1.16B | 2.77% | 340,565 | 2.73B |
| 329 | NNNN | Anbio Biotechnology | 1.14B | 1.28% | 3,189 | 6.92M |
| 330 | ALVO | Alvotech | 1.13B | -0.55% | 46,199 | 588.90M |
| 331 | EYPT | EyePoint, Inc. | 1.12B | 2.69% | 353,078 | 31.37M |
| 332 | USPH | U.S. Physical Therapy, Inc. | 1.11B | -1.22% | 30,545 | 773.34M |
| 333 | SEPN | Septerna, Inc. | 1.10B | 0.53% | 48,095 | 45.95M |
| 334 | CNMD | CONMED Corporation | 1.09B | -0.82% | 75,142 | 1.37B |
| 335 | GERN | Geron Corporation | 1.08B | 1.51% | 9,655,233 | 183.88M |
| 336 | ABCL | AbCellera Biologics Inc. | 1.08B | 1.42% | 1,050,355 | 75.13M |
| 337 | AVBP | ArriVent BioPharma, Inc. | 1.07B | 0.04% | 135,781 | - |
| 338 | BFLY | Butterfly Network, Inc. | 1.07B | 2.44% | 1,759,737 | 97.61M |
| 339 | QURE | uniQure N.V. | 1.06B | 0.65% | 480,901 | 16.10M |
| 340 | PNTG | The Pennant Group, Inc. | 1.06B | -0.30% | 37,369 | 947.71M |
| 341 | XERS | Xeris Biopharma Holdings, Inc. | 1.05B | 0.83% | 465,362 | 291.85M |
| 342 | COLL | Collegium Pharmaceutical, Inc. | 1.05B | -0.75% | 129,549 | 780.57M |
| 343 | INNV | InnovAge Holding Corp. | 1.03B | -5.11% | 85,911 | 915.37M |
| 344 | NEO | NeoGenomics, Inc. | 1.02B | 1.68% | 664,668 | 727.33M |
| 345 | IVA | Inventiva S.A. | 1.01B | 3.13% | 220,906 | 9.31M |
| 346 | AZTA | Azenta, Inc. | 1.01B | 3.97% | 310,798 | 595.03M |
| 347 | KALV | KalVista Pharmaceuticals, Inc. | 1.01B | -0.10% | 182,363 | 73.62M |
| 348 | STAA | STAAR Surgical Company | 989.76M | 3.41% | 313,099 | 239.44M |
| 349 | SSII | SS Innovations International, Inc. | 987.70M | 1.86% | 10,305 | 42.48M |
| 350 | CTMX | CytomX Therapeutics, Inc. | 968.47M | -1.75% | 826,102 | 76.20M |
| 351 | CMPX | Compass Therapeutics, Inc. | 951.76M | -2.67% | 1,464,243 | 850.00K |
| 352 | CRON | Cronos Group Inc. | 949.79M | -0.20% | 292,855 | 146.59M |
| 353 | INBX | Inhibrx Biosciences, Inc. | 946.32M | -3.38% | 70,599 | 1.30M |
| 354 | TDOC | Teladoc Health, Inc. | 943.72M | 0.19% | 1,710,704 | 2.53B |
| 355 | BLFS | BioLife Solutions, Inc. | 936.05M | 0.47% | 45,562 | 96.21M |
| 356 | AKTS | Aktis Oncology, Inc. | 934.86M | -0.92% | 77,624 | 6.50M |
| 357 | CDNA | CareDx, Inc. | 933.16M | 1.96% | 87,541 | 379.81M |
| 358 | MPLT | MapLight Therapeutics, Inc. | 931.55M | 1.58% | 36,025 | - |
| 359 | AMPH | Amphastar Pharmaceuticals, Inc. | 930.54M | 1.33% | 87,717 | 719.89M |
| 360 | PCRX | Pacira BioSciences, Inc. | 924.99M | 0.24% | 98,484 | 726.41M |
| 361 | URGN | UroGen Pharma Ltd. | 924.96M | 0.32% | 116,834 | 109.79M |
| 362 | LMRI | Lumexa Imaging Holdings, Inc. | 924.58M | 2.34% | 185,759 | 1.02B |
| 363 | EVO | Evotec SE | 917.70M | 1.18% | 28,283 | 887.40M |
| 364 | XNCR | Xencor, Inc. | 913.80M | -0.56% | 148,662 | 125.58M |
| 365 | CLOV | Clover Health Investments, Corp. | 910.30M | 2.06% | 1,019,592 | 1.92B |
| 366 | PHAT | Phathom Pharmaceuticals, Inc. | 895.94M | 2.06% | 198,771 | 175.11M |
| 367 | ANNX | Annexon, Inc. | 893.04M | 3.82% | 704,069 | - |
| 368 | FTRE | Fortrea Holdings Inc. | 892.93M | 0.42% | 270,001 | 2.72B |
| 369 | JANX | Janux Therapeutics, Inc. | 889.97M | 0.83% | 290,414 | 10.00M |
| 370 | GHRS | GH Research PLC | 889.50M | -2.58% | 34,107 | - |
| 371 | ABUS | Arbutus Biopharma Corporation | 872.81M | -1.22% | 159,039 | 14.08M |
| 372 | INMD | InMode Ltd. | 871.18M | 0.36% | 271,228 | 370.50M |
| 373 | CERT | Certara, Inc. | 868.90M | -0.73% | 1,266,226 | 418.84M |
| 374 | TALK | Talkspace, Inc. | 864.62M | 0.29% | 846,562 | 228.87M |
| 375 | OPK | OPKO Health, Inc. | 861.54M | 0.44% | 371,095 | 606.88M |
| 376 | SDGR | Schrödinger, Inc. | 856.37M | 0.43% | 234,422 | 255.87M |
| 377 | CGEM | Cullinan Therapeutics, Inc. | 834.05M | -1.15% | 695,726 | - |
| 378 | ORIC | ORIC Pharmaceuticals, Inc. | 832.97M | 11.04% | 3,072,103 | - |
| 379 | SANA | Sana Biotechnology, Inc. | 829.96M | 1.97% | 1,574,662 | - |
| 380 | EVMN | Evommune, Inc. | 826.62M | 2.36% | 98,508 | 13.00M |
| 381 | TBPH | Theravance Biopharma, Inc. | 824.40M | 1.07% | 116,707 | 107.46M |
| 382 | OMER | Omeros Corporation | 804.20M | -7.53% | 847,630 | - |
| 383 | SPRY | ARS Pharmaceuticals, Inc. | 802.32M | -0.37% | 627,196 | 84.28M |
| 384 | BIOA | BioAge Labs, Inc. | 800.17M | 1.69% | 51,076 | 9.00M |
| 385 | TENX | Tenax Therapeutics, Inc. | 774.63M | -3.75% | 195,380 | - |
| 386 | JBIO | Jade Biosciences, Inc. | 772.79M | -2.18% | 146,987 | - |
| 387 | SGP | SpyGlass Pharma, Inc. | 771.30M | -5.28% | 38,784 | - |
| 388 | KURA | Kura Oncology, Inc. | 766.70M | 4.08% | 2,954,705 | 67.48M |
| 389 | VOR | Vor Biopharma Inc. | 754.42M | 4.49% | 473,636 | - |
| 390 | MNKD | MannKind Corporation | 753.31M | -3.74% | 962,089 | 348.97M |
| 391 | TLRY | Tilray Brands, Inc. | 750.30M | 4.89% | 2,767,509 | 837.32M |
| 392 | IART | Integra LifeSciences Holdings Corporation | 748.98M | 0.42% | 155,785 | 1.64B |
| 393 | CSTL | Castle Biosciences, Inc. | 748.33M | 0.48% | 50,889 | 344.23M |
| 394 | OMDA | Omada Health, Inc. | 747.76M | 0.63% | 314,498 | 260.21M |
| 395 | MRVI | Maravai LifeSciences Holdings, Inc. | 746.78M | 1.22% | 385,606 | 185.74M |
| 396 | SLDB | Solid Biosciences Inc. | 745.31M | 2.64% | 198,118 | - |
| 397 | MGTX | MeiraGTx Holdings plc | 741.97M | 0.22% | 481,814 | 81.39M |
| 398 | BVS | Bioventus Inc. | 738.83M | -2.90% | 105,839 | 568.09M |
| 399 | SLS | SELLAS Life Sciences Group, Inc. | 738.08M | -2.38% | 1,582,474 | - |
| 400 | CMPS | COMPASS Pathways plc | 732.28M | 1.07% | 404,972 | - |
| 401 | RLMD | Relmada Therapeutics, Inc. | 718.50M | -3.52% | 1,060,716 | - |
| 402 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 715.49M | -1.00% | 45,694 | - |
| 403 | EHAB | Enhabit, Inc. | 710.13M | 0.21% | 437,792 | 1.06B |
| 404 | PSNL | Personalis, Inc. | 701.03M | 2.13% | 288,890 | 69.65M |
| 405 | CBLL | CeriBell, Inc. | 696.36M | - | 66,503 | 89.06M |
| 406 | ETON | Eton Pharmaceuticals, Inc. | 695.75M | 0.55% | 166,881 | 79.95M |
| 407 | DRUG | Bright Minds Biosciences Inc. | 691.10M | -1.56% | 54,911 | - |
| 408 | ARVN | Arvinas, Inc. | 689.50M | -4.85% | 803,943 | 262.60M |
| 409 | ANRO | Alto Neuroscience, Inc. | 687.63M | -8.05% | 359,979 | - |
| 410 | GDRX | GoodRx Holdings, Inc. | 686.86M | -0.25% | 358,595 | 796.85M |
| 411 | AMN | AMN Healthcare Services, Inc. | 685.76M | -4.42% | 173,324 | 2.73B |
| 412 | NUTX | Nutex Health Inc. | 683.87M | -0.30% | 59,312 | 875.26M |
| 413 | DSGN | Design Therapeutics, Inc. | 680.25M | 0.18% | 152,823 | - |
| 414 | LXRX | Lexicon Pharmaceuticals, Inc. | 673.65M | -3.05% | 671,716 | 49.80M |
| 415 | ESPR | Esperion Therapeutics, Inc. | 660.00M | -1.53% | 2,116,480 | 403.14M |
| 416 | CBIO | Crescent Biopharma, Inc. | 657.97M | 2.54% | 107,589 | 10.84M |
| 417 | AVNS | Avanos Medical, Inc. | 654.83M | -0.07% | 72,857 | 701.20M |
| 418 | REPL | Replimune Group, Inc. | 647.37M | 3.02% | 759,228 | - |
| 419 | GYRE | Gyre Therapeutics, Inc. | 641.02M | -2.90% | 24,274 | 116.59M |
| 420 | LBRX | LB Pharmaceuticals Inc | 630.96M | 0.52% | 89,537 | - |
| 421 | ALLO | Allogene Therapeutics, Inc. | 622.85M | -0.20% | 1,616,452 | 22.00K |
| 422 | DRTS | Alpha Tau Medical Ltd. | 612.55M | 0.58% | 62,546 | - |
| 423 | PRME | Prime Medicine, Inc. | 598.53M | -0.29% | 562,879 | 4.63M |
| 424 | HSTM | HealthStream, Inc. | 597.40M | -0.25% | 29,239 | 304.06M |
| 425 | IRWD | Ironwood Pharmaceuticals, Inc. | 595.16M | -6.41% | 502,881 | 296.15M |
| 426 | OCGN | Ocugen, Inc. | 594.70M | -1.68% | 2,487,926 | 4.41M |
| 427 | TECX | Tectonic Therapeutic, Inc. | 590.15M | 2.11% | 49,450 | - |
| 428 | CTKB | Cytek Biosciences, Inc. | 587.47M | 2.01% | 143,059 | 201.49M |
| 429 | ACRS | Aclaris Therapeutics, Inc. | 578.91M | 0.60% | 243,928 | 7.83M |
| 430 | TCMD | Tactile Systems Technology, Inc. | 578.32M | -2.12% | 43,876 | 329.52M |
| 431 | SIBN | SI-BONE, Inc. | 577.02M | 0.42% | 131,382 | 200.93M |
| 432 | MDXG | MiMedx Group, Inc. | 575.70M | -1.90% | 579,725 | 418.63M |
| 433 | VALN | Valneva SE | 569.36M | -2.39% | 218,014 | 205.07M |
| 434 | ZURA | Zura Bio Limited | 562.17M | -1.74% | 133,046 | - |
| 435 | PROK | ProKidney Corp. | 555.53M | 5.14% | 556,508 | 893.00K |
| 436 | CRMD | CorMedix Inc. | 554.93M | - | 292,385 | 311.71M |
| 437 | ZVRA | Zevra Therapeutics, Inc. | 549.54M | -0.53% | 199,350 | 106.47M |
| 438 | BWAY | BrainsWay Ltd. | 543.19M | -0.41% | 97,224 | 52.23M |
| 439 | KYTX | Kyverna Therapeutics, Inc. | 538.05M | 1.48% | 221,036 | - |
| 440 | EIKN | Eikon Therapeutics, Inc. | 537.68M | -1.19% | 29,413 | - |
| 441 | AGMB | AgomAb Therapeutics NV | 537.57M | -6.37% | 33,074 | - |
| 442 | PRTA | Prothena Corporation plc | 533.48M | -1.20% | 123,211 | 9.68M |
| 443 | FULC | Fulcrum Therapeutics, Inc. | 522.81M | 4.95% | 216,012 | 80.00M |
| 444 | EMBC | Embecta Corp. | 518.77M | -0.34% | 246,217 | 1.08B |
| 445 | VTVT | vTv Therapeutics Inc. | 515.06M | 2.41% | 29,272 | 17.00K |
| 446 | CATX | Perspective Therapeutics, Inc. | 509.85M | 1.24% | 286,161 | 884.00K |
| 447 | AVR | Anteris Technologies Global Corp. | 509.24M | 0.66% | 173,432 | 1.91M |
| 448 | RIGL | Rigel Pharmaceuticals, Inc. | 508.01M | - | 53,381 | 294.28M |
| 449 | UPB | Upstream Bio, Inc. | 504.75M | -0.38% | 151,546 | 2.85M |
| 450 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 451 | CTNM | Contineum Therapeutics, Inc. | 502.17M | - | 28,422 | - |
| 452 | PHR | Phreesia, Inc. | 501.70M | -1.55% | 894,566 | 480.59M |
| 453 | AQST | Aquestive Therapeutics, Inc. | 499.16M | -0.97% | 229,873 | 44.55M |
| 454 | VSTM | Verastem, Inc. | 496.27M | 1.80% | 646,915 | 30.91M |
| 455 | FDMT | 4D Molecular Therapeutics, Inc. | 493.16M | -2.13% | 208,736 | 85.21M |
| 456 | LRMR | Larimar Therapeutics, Inc. | 491.89M | 1.18% | 175,726 | - |
| 457 | LYEL | Lyell Immunopharma, Inc. | 491.55M | 1.35% | 27,365 | 36.00K |
| 458 | YDES | YD Bio Limited | 490.83M | -4.25% | 2,398 | 510.36K |
| 459 | NPCE | NeuroPace, Inc. | 482.62M | 1.88% | 55,159 | 99.99M |
| 460 | ABSI | Absci Corporation | 482.02M | - | 1,734,168 | 2.80M |
| 461 | ANGO | AngioDynamics, Inc. | 481.83M | -2.09% | 430,304 | 313.73M |
| 462 | IMMX | Immix Biopharma, Inc. | 481.45M | 5.45% | 237,275 | - |
| 463 | FLGT | Fulgent Genetics, Inc. | 477.67M | 0.73% | 106,181 | 322.67M |
| 464 | KMDA | Kamada Ltd. | 475.22M | -0.35% | 3,842 | 180.46M |
| 465 | ADCT | ADC Therapeutics SA | 475.15M | -1.58% | 433,493 | 81.36M |
| 466 | TRDA | Entrada Therapeutics, Inc. | 469.44M | -3.26% | 44,296 | 25.42M |
| 467 | OFIX | Orthofix Medical Inc. | 464.47M | -0.34% | 63,907 | 822.31M |
| 468 | AVIR | Atea Pharmaceuticals, Inc. | 459.31M | 2.04% | 110,157 | - |
| 469 | ASMB | Assembly Biosciences, Inc. | 459.23M | -1.63% | 6,241 | 72.30M |
| 470 | EPRX | Eupraxia Pharmaceuticals Inc. | 456.57M | -1.91% | 50,205 | - |
| 471 | BBNX | Beta Bionics, Inc. | 454.92M | 2.40% | 136,189 | 100.25M |
| 472 | ENGN | enGene Holdings Inc. | 450.17M | -0.59% | 30,162 | - |
| 473 | STTK | Shattuck Labs, Inc. | 445.13M | -0.48% | 148,864 | 1.00M |
| 474 | FBRX | Forte Biosciences, Inc. | 444.00M | 0.16% | 49,742 | - |
| 475 | VREX | Varex Imaging Corporation | 440.36M | -1.08% | 28,447 | 854.40M |
| 476 | RGNX | REGENXBIO Inc. | 438.19M | -1.62% | 121,079 | 170.44M |
| 477 | ALT | Altimmune, Inc. | 431.30M | 6.25% | 1,349,460 | 41.00K |
| 478 | MYGN | Myriad Genetics, Inc. | 429.20M | - | 254,193 | 824.50M |
| 479 | LXEO | Lexeo Therapeutics, Inc. | 426.00M | 1.41% | 125,890 | - |
| 480 | EBS | Emergent BioSolutions Inc. | 425.55M | -1.67% | 195,463 | 742.90M |
| 481 | AURA | Aura Biosciences, Inc. | 424.03M | -1.34% | 43,027 | - |
| 482 | NAUT | Nautilus Biotechnology, Inc. | 422.73M | -0.45% | 96,414 | - |
| 483 | AUNA | Auna S.A. | 417.43M | 0.36% | 43,780 | 1.30B |
| 484 | DNA | Ginkgo Bioworks Holdings, Inc. | 408.62M | 3.39% | 541,808 | 170.16M |
| 485 | STRO | Sutro Biopharma, Inc. | 408.38M | -0.88% | 66,078 | 102.48M |
| 486 | PACB | Pacific Biosciences of California, Inc. | 404.68M | -0.74% | 1,817,320 | 160.01M |
| 487 | KIDS | OrthoPediatrics Corp. | 404.21M | -1.84% | 24,311 | 236.35M |
| 488 | VNDA | Vanda Pharmaceuticals Inc. | 403.71M | -3.39% | 278,740 | 216.11M |
| 489 | CYH | Community Health Systems, Inc. | 397.58M | - | 303,185 | 12.49B |
| 490 | NRC | National Research Corporation | 397.38M | 0.75% | 19,200 | 137.39M |
| 491 | IPSC | Century Therapeutics, Inc. | 397.19M | 0.91% | 189,147 | 109.16M |
| 492 | XOMA | XOMA Royalty Corporation | 396.32M | 0.54% | 45,090 | 52.15M |
| 493 | RCKT | Rocket Pharmaceuticals, Inc. | 394.11M | 0.28% | 483,754 | - |
| 494 | LCTX | Lineage Cell Therapeutics, Inc. | 393.56M | -0.63% | 209,639 | 14.56M |
| 495 | AVTX | Avalo Therapeutics, Inc. | 387.40M | 1.80% | 442,964 | 59.00K |
| 496 | XFOR | X4 Pharmaceuticals, Inc. | 387.32M | -2.07% | 79,718 | 35.11M |
| 497 | ARMP | Armata Pharmaceuticals, Inc. | 386.84M | - | 4,926 | 4.90M |
| 498 | WEAV | Weave Communications, Inc. | 381.84M | 2.43% | 364,334 | 239.02M |
| 499 | NMRA | Neumora Therapeutics, Inc. | 381.38M | 0.24% | 536,850 | - |
| 500 | ENTA | Enanta Pharmaceuticals, Inc. | 379.86M | 0.93% | 23,615 | 66.98M |